Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress

被引：0
|
作者：
Park, S. H. [1 ]
Amissi, S. [1 ]
Algara-Suarez, P. [1 ]
Gong, D. S. [1 ]
Mroueh, A. [1 ]
Belcastro, E. [1 ]
Matsushita, K. [1 ]
Bruckert, C. [1 ]
Chaker, A. B. [1 ]
Jesel, L. [2 ]
Ohlmann, P. [2 ]
Morel, O. [2 ]
Mazzucotelli, J. P. [2 ]
Schini-Kerth, V. B. [1 ]
机构：
[1] Univ Strasbourg, INSERM UMR 1260, Regenerat Nanomed, Strasbourg, France
[2] Univ Hosp Strasbourg, Cardiol, Strasbourg, France
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3440 / 3440
页数：1
相关论文
共 50 条
  • [11] Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly reply
    Gomez-Huelgas, Ricardo
    Perez-Belmonte, Luis M.
    Lopez-Sampalo, Almudena
    Morilla--Herrera, Juan C.
    Bellosta-Ymbert, Jose M.
    Bernal-Lopez, M. Rosa
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (02): : 940 - 940
  • [12] A Role of Sodium-Glucose Co-Transporter 2 in Cardiorenal Anemia Iron Deficiency Syndrome
    Sano, Motoaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [13] The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors
    Swislocki, Arthur L. M.
    Jialal, Ishwarlal
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (07) : 287 - 291
  • [14] Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors
    Isaacs, Michelle
    Tonks, Katherine T.
    Greenfield, Jerry R.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (06) : 701 - 704
  • [15] PRO: Should Patients Taking Sodium-Glucose Co-Transporter 2 Inhibitors Be Dropped From the Elective Surgical Program?
    Ryz, Sylvia
    Castellucci, Clara
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (07) : 1587 - 1589
  • [16] The effect of sodium-glucose co-transporter-2 inhibitors on the pro-inflammatory cytokines secretions: A potential anti-inflammatory effect
    Alshnbari, A. S.
    Millar, S. A.
    Khan, R.
    O'Sullivan, S. E.
    Idris, I.
    DIABETIC MEDICINE, 2020, 37 : 63 - 63
  • [17] Emerging Role of Sodium-Glucose Co-Transporter 2 Inhibitors for the Treatment of Chronic Kidney Disease
    Isidto, Rey
    Danguilan, Romina
    Naidas, Oscar
    Vilanueva, Russell
    Arakama, Mel-Hatra
    Paraiso, Layla Marie
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2023, 16 : 43 - 57
  • [18] The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors
    Butler, Javed
    Hamo, Carine E.
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Bernstein, Richard A.
    Brueckmann, Martina
    Cheung, Alfred K.
    George, Jyothis T.
    Green, Jennifer B.
    Januzzi, James L.
    Kaul, Sanjay
    Lam, Carolyn S. P.
    Lip, Gregory Y. H.
    Marx, Nikolaus
    McCullough, Peter A.
    Mehta, Cyrus R.
    Ponikowski, Piotr
    Rosenstock, Julio
    Sattar, Naveed
    Salsali, Afshin
    Scirica, Benjamin M.
    Shah, Sanjiv J.
    Tsutsui, Hiroyuki
    Verma, Subodh
    Wanner, Christoph
    Woerle, Hans-Juergan
    Zannad, Faiez
    Anker, Stefan D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1390 - 1400
  • [19] Protective Role of Sodium-Glucose Co-Transporter 2 Inhibition Against Vascular Complications in Diabetes
    Yamagishi, Sho-ichi
    Matsui, Takanori
    REJUVENATION RESEARCH, 2016, 19 (02) : 107 - 114
  • [20] How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients
    Zaina, Adnan
    Prencipe, Nunzia
    Golden, Elena
    Berton, Alessandro Maria
    Arad, Eldad
    Abid, Ali
    Shehadeh, Jeryes
    Kassem, Sameer
    Ghigo, Ezio
    ENDOCRINE, 2023, 80 (03) : 491 - 499
12345